Business Insights

Welcome to What Tech Can Do, the podcast series from Roland Berger's Advanced Technology Center that provides insights into technological and industrial shifts and helps build the foundation for successful business strategies based on operational realities.

In this first episode, Junhyuk Choi, Senior Project Manager at Alexec (a Roland Berger company), is joined by Idriss Alami, Managing Partner at Alexec, and Wolfgang Bernhart, Senior Partner and Co-Head of the Advanced Technology Center at Roland Berger, to discuss the realities of scaling battery production in gigafactories. They
explore why the start of production (SOP) marks the beginning of the most challenging...

In this episode, our partner Florian Dehne, Global Head Aviation, speaks with Martin Gauss, long-time CEO of Air Baltic and since November CEO of Gulf Air, about his fascinating journey from pilot to airline leader – and the lessons he’s learned along the way. Together, they explore how artificial intelligence, digitalization, and simplicity are reshaping the aviation industry.
Martin shares insights on driving innovation through AI-based revenue management, Starlink connectivity, blockchain loyalty programs, and his belief that the passenger experience must become simpler, more seamless, and customer-centric. Discover how smaller, agile airlines can lead transformation and why AI will soon...

In this episode, Atlas Air’s Richard Broekman and Katherine Preston join our expert Nikhil Sachdeva to discuss how the air cargo industry is moving forward with decarbonization, even amid geopolitical and market disruptions.

The conversation covers Atlas Air’s targets, its investments in sustainable aviation fuel, fleet modernization, and operational efficiency. As the sector faces both regulatory complexity and supply chain volatility, the focus is shifting from long-term ambition to actionable progress. What role will air cargo play in enabling greener global trade?

For more information, visit our website at rolandberger.com.

In this episode on the future of healthcare, our partner Thilo Kaltenbach speaks with Prof. Dr. med. Harald HHW Schmidt about the rise of network pharmacology and its potential to transform pharmaceutical research and development. The conversation explores how moving beyond organ-based definitions of disease could enable a step change in treating root causes rather than symptoms.
What will this mean for pharma business models, clinical pathways, and the health systems of tomorrow?
For more information, visit our website at rolandberger.com.